Cargando…
A regulatory perspective on recombinant collagen-based medical devices
As a class of novel biomaterials manufactured by synthetic biology technologies, recombinant collagens are candidates for a variety of medical applications. In this article, a regulatory scientific perspective on recombinant collagens and their medical devices is presented with a focus on the defini...
Autores principales: | Liu, Wenbo, Lin, Hai, Zhao, Peng, Xing, Lina, Li, Jie, Wang, Zehua, Ju, Shan, Shi, XinLi, Liu, Yinghui, Deng, Gang, Gao, Guobiao, Sun, Lei, Zhang, Xindong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897173/ https://www.ncbi.nlm.nih.gov/pubmed/35310384 http://dx.doi.org/10.1016/j.bioactmat.2021.10.031 |
Ejemplares similares
-
Current controversies in glia-to-neuron conversion therapy in neurodegenerative diseases
por: Cao, Peng, et al.
Publicado: (2023) -
Plain metallic biomaterials: opportunities and challenges
por: Zhang, Jiazhen, et al.
Publicado: (2022) -
Preference Testing in Medical Devices: Current Framework and Regulatory Gaps
por: Lewis, Amy, et al.
Publicado: (2022) -
Software to manage regulatory workflows for medical device development at academic medical centers: A critical gap
por: Rose, Lynn, et al.
Publicado: (2023) -
Perspective on the integration of optical sensing into orthopedic surgical devices
por: Fisher, Carl, et al.
Publicado: (2022)